Society ❯ Health Issues ❯ Obesity

Weight Management

Public Health Pharmaceutical Solutions Medication Accessibility Medication Use Drug Accessibility Dieting Trends Treatment Options Dietary Supplements Mounjaro Dietary Treatments Weight-loss Drugs Dietary Medications Medication Access Injectable Treatments Wegovy Medication Abuse Lifestyle Changes Public Perception of Weight Loss Drug Dependency Drug Affordability Community Support Patient Experiences Personal Experiences Consumer Health GLP-1 Drugs Access to Medication Public Health Policies Patient Care Patient Eligibility Dietary Interventions Public Health Initiatives Pharmaceuticals

Employers Trim Coverage of GLP-1 Weight-Loss Drugs

Plans are cutting or limiting benefits to rein in rising short-term health costs while officials say lower net prices over the next two to three years could bring coverage back.

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

States Curb Medicaid Coverage as First GLP‑1 Weight‑Loss Pill Debuts and Cash Prices Fall

Trump Pledges Sharp Cuts to GLP-1 Drug Prices as Novo, Lilly Shares Slide